Linda is Barclay Damon's health care controversies team leader. A nationally recognized litigator with over 30 years of experience, she serves as lead litigation counsel as well as national, regional, and local counsel in the prosecution and defense of claims brought in state and federal courts on behalf of large groups of business and institutional clients.
Linda is a trusted advisor to health care providers, pharmaceutical companies, and pharmacies nationwide in resolving high-stakes disputes and government investigations and regulatory proceedings. She represents health care professionals and entities in all types of civil, criminal, and administrative proceedings, hearings, and appeals before various federal and state regulatory agencies, including the NYS Office of the Medicaid Inspector General (OMIG), the NYS Attorney General’s Office (OAG) the NYS Department of Health (DOH), and their federal counterparts, including the Office of Inspector General (OIG) and the United States Department of Justice (DOJ) among others.
Linda's practice additionally focuses on complex multiparty group and class-action litigation in state and federal courts in New York and beyond. She has extensive experience serving as regional, national, and trial counsel, representing drug manufacturers, product manufacturers, and contractors in the defense of class-certification applications and mass-tort claims.
In addition to her role at Barclay Damon, for over 20 years, Linda served as court-appointed defense liaison counsel for three jurisdictions in the Northern District of New York in asbestos litigation, working with hundreds of defense firms and the judiciary in the administration of these cases. She also currently serves as a court appointee to several high-profile administrative committees for the NYS and federal court systems and has served as a judicial hearing officer for five years, hearing cases involving alleged judicial misconduct by the judiciary.